PCOS Just Got a New Name… And I Think It's Long Overdue

Published May 12, 2026

Polycystic Ovary Syndrome (PCOS) has officially been renamed. Published today in The Lancet and backed by 56 global organizations, the condition will now be known as Polyendocrine Metabolic Ovarian Syndrome — PMOS.

As a dietitian who works exclusively with people who have this condition, my reaction was simple: it's about time.

What the New Name Actually Means

Let's break it down, because the name change isn't just cosmetic — it's a corrective:

• Polyendocrine = this condition affects multiple hormonal systems, not just one

• Metabolic = insulin resistance and metabolic health are central to what's happening

• Ovarian = yes, ovulation and reproductive health are part of the picture

• Syndrome = a collection of symptoms that looks different on everyone

That last point matters more than people realize. PMOS doesn't have one universal presentation. It shows up differently depending on the person, and a name that reflects that complexity helps everyone, patients, providers, AND researchers, understand what they're actually dealing with.

Why "Polycystic" Was Always the Wrong Word

Here's something I've said to clients more times than I can count: you don't need cysts to have PCOS. And yet, the word "polycystic" was right there in the name, creating years of confusion. And, more importantly, misdiagnosis.

What many women with this condition actually had on their ultrasounds weren't cysts at all. They were follicles — immature follicles that couldn't complete ovulation. That's a fundamentally different finding, and "polycystic" flattened that distinction entirely.

I've heard too many stories of women waiting six months to see a specialist, being told they don't have PCOS because they don't have cysts on their ovary, and then walking out with no diagnosis and no treatment… while dealing with irregular cycles, weight gain around the abdomen, facial hair, anxiety, and sleep apnea. That person was suffering. And they were being turned away based on a misleading name.

This isn't a rebrand. It's a correction.

This Is Bigger Than Fertility

One of the most harmful narratives around this condition is that it's just a fertility issue. It's not. Full stop. And for those who don’t desire to have children, that framing can mean years of inadequate care.

PMOS is a complex, multi-system condition with real long-term health implications:

• 40-50% of people with PMOS will develop type 2 diabetes by age 40

• Increased risk of cardiovascular disease, fatty liver disease, and stroke

• Hormonal and metabolic dysfunction that persists across the lifespan (beyond menopause!)

And this condition does not disappear after you have kids. It stays with you. Which means treatment needs to stay with you, too.

Every person with PMOS should be getting a full metabolic workup. Fasting insulin, fasting glucose, livery enzymes and lipids. At diagnosis and on an ongoing basis. This is the picture we need to be looking at.

What I'm Watching For Next

This name change has real downstream implications, and I'm genuinely curious to see how they unfold.

Renaming a condition that lives in ICD-10 codes and insurance billing takes time. There's a three-year adoption timeline in place. But I'm hopeful. Because if metabolic health is now explicitly part of this condition's name and definition, it opens the door to better treatment coverage. Will we start to see improved insurance access for GLP-1 medications, for example? I think that's a legitimate question worth asking.

I also hope this shifts how doctors approach diagnosis and treatment from the start. No more handing someone a birth control prescription and sending them home, and more full metabolic and hormonal panels.

Where I Stand

I'm not waiting three years. I'm using PMOS now.

I want my clients to understand what is actually happening in their bodies — not just today, but across their lifetime. A name that reflects the hormonal complexity, the metabolic involvement, and the systemic nature of this condition is a better starting point for that conversation.

More than anything, I hope this reduces stigma. I hope it improves diagnosis. I hope it shifts the focus toward the full metabolic and hormonal picture that so many people with this condition deserve to have taken seriously.

Women deserve healthcare that reflects their reality. This name is a step in that direction, and that, I am here for.

Kat is a Registered Dietitian and founder of Alike Nutrition, a virtual PCOS-specialized dietitian practice in the US.